How to Taper Off Lexapro: A Safe, Step-by-Step Guide
Author:
Blossom Editorial
May 1, 2026
Stopping Lexapro (escitalopram) is a process that should be done gradually and only under medical supervision. When done too quickly or without guidance, stopping Lexapro can trigger a cluster of physical and emotional symptoms known as antidepressant discontinuation syndrome. These symptoms are not a sign of addiction, nor do they mean the medication was harmful — they reflect the brain and nervous system adjusting to the absence of the medication after neuroadaptation during treatment.
Whether you are considering getting off Lexapro soon or you are simply trying to understand what to expect, this guide covers the research on tapering, what a realistic schedule looks like, how to manage symptoms along the way, and the warning signs that should prompt you to call your prescriber.
Key Takeaways
Stopping Lexapro abruptly significantly increases the risk and severity of discontinuation syndrome; a slow, structured taper with medical guidance is generally considered the safest approach for most people.
Many clinicians reduce the dose gradually (for example, 10–25% at a time), but the optimal taper varies widely between individuals. People who have been on Lexapro for years, or at higher doses, often need a much longer taper, sometimes 6 to 12 months. A longer taper period and going down to doses much lower than minimum therapeutic levels has shown success for some people.
Deciding when to stop Lexapro is just as important as how — guidelines generally recommend staying on antidepressants for at least 6 months after full remission before discontinuation to reduce the risk of relapse. Those who’ve had recurrent depressive episodes in the past or have a strong family history may require a longer treatment duration.
Should You Stop Taking Lexapro?
Before thinking about how to taper, it is worth considering whether now is the right time. Stopping an antidepressant too early is a common contributor to relapse in depression and anxiety disorders. A recent meta-analysis found a relapse rate of around 35% after six months of discontinuing antidepressants, with the duration of treatment being associated with the risk of relapse.
According to the American Psychiatric Association, people taking antidepressants are typically advised to remain on treatment for at least six months after remission. Those who have had recurrent depressive episodes in the past or with a strong family history of depression may benefit from a longer maintenance treatment.
Good candidates for discontinuation are generally those who have been stable and symptom-free for an extended period, feel well-supported with coping tools (including therapy), are not currently under major life stressors, and have had a clear conversation with their prescriber about the risks and timing. If multiple depressive episodes are in your history, your provider may recommend staying on medication longer before attempting a taper.
What is Antidepressant Discontinuation Syndrome?
Antidepressant discontinuation syndrome (also called withdrawal syndrome) occurs when SSRIs like Lexapro are stopped abruptly or reduced too quickly. It is distinct from addiction — there is no drug-seeking behavior or psychological compulsion involved.
What happens is that the brain's neurological system has adapted to the presence of the medication, and when the medication is suddenly removed, it needs time to recalibrate. This causes one or more symptoms, which can begin a few days after discontinuation and last up to weeks or months for some people.
A systematic review and meta-analysis published in The Lancet Psychiatry, including 79 studies, found that roughly one in three patients will have at least one discontinuation symptom after antidepressant discontinuation. One in 35 patients (around 3%) will have severe discontinuation symptoms.
Most guidelines recommend gradually tapering an antidepressant dosage before discontinuation to minimize the severity of discontinuation symptoms. Recognizing the symptom pattern early and knowing what to do makes a meaningful difference in how manageable the process is.
The FINISH mnemonic captures the common symptoms: Flu-like symptoms (chills, aches, sweating), Insomnia and vivid dreams, Nausea and GI distress, Imbalance and dizziness, Sensory disturbances including electric shock-like "brain zaps", and Hyperarousal such as anxiety, irritability, and mood swings.
In rare cases, antidepressant discontinuation can induce mania or hypomania, emotional blunting, and long-term sexual dysfunction.
How Long Does a Lexapro Taper Take?
The honest answer is: it depends. Taper duration is influenced by how long you have been on Lexapro, your current dose, whether you have had discontinuation symptoms before, and how sensitive your nervous system is to serotonin changes. Some people can taper over weeks, while others — especially after long-term use — may require several months or longer
A landmark 2019 paper in The Lancet Psychiatry argued that standard taper schedules often cut doses too aggressively at the lower end — for example, going from 5 mg to zero can be a 100% reduction relative to the dose — and that very gradual, "hyperbolic" tapering strategies (reducing by a smaller percentage each step) produce fewer and less severe symptoms.
Thus, tapering SSRIs over a period of a few months and going down to doses much lower than minimum therapeutic levels may be more suitable in some cases. This approach is increasingly discussed in the literature, though practices vary among clinicians.
A Typical Lexapro Taper Schedule
The following is a general framework. Your actual schedule should always be individualized by your prescriber.
Standard 20 mg Taper Example
Weeks 1-2: Reduce to 15 mg daily
Weeks 3-4: Reduce to 10 mg daily
Weeks 5-6: Reduce to 5 mg daily
Week 7: Discontinue or switch to 5 mg every alternate day, based on provider’s guidance
Although this schedule may work for some people, some clinicians recommend smaller reductions of 10-25% or 5-10% every 1-2 weeks to reduce the risk of developing withdrawal symptoms.
Slower Hyperbolic Taper for Sensitive Individuals
Lexapro is available as an oral liquid (1 mg/mL), which allows for very small, precise dose reductions when needed. This is particularly valuable for patients tapering off the lowest tablet dose of 5 mg — cutting a 5 mg tablet in half is difficult and imprecise, and going from 5 mg to zero is a large relative jump. Using liquid allows reductions of 1 to 2 mg at a time, giving the nervous system more opportunity to adjust smoothly.
A case report detailing a hyperbolic dose reduction of Lexapro in a patient having co-existing depression and anxiety and with a history of severe discontinuation syndrome demonstrated a successful taper that resulted in minimal withdrawal symptoms. The dosage was reduced weekly from 10 mg to 5 mg, 3 mg, 2 mg, 1.5 mg, 1 mg, 0.5 mg, and 0.25 mg over 7 weeks before being stopped. Moreover, the patient experienced no further withdrawal symptoms, anxiety, or depression 12 weeks after discontinuation of Lexapro.
Note: Examples of taper schedule and hyperbolic dose reduction are for informational purposes only and are not to be taken as individual prescription or dosage advice. Do not stop, start, or change medication or dosage without consulting your provider.
Managing Symptoms During Your Taper
Even a carefully structured taper may produce some symptoms. These strategies can reduce their impact:
Take your dose at the same time each day — consistency helps maintain stable blood levels and reduces fluctuations that trigger symptoms
Track symptoms in a daily log — this helps you and your prescriber assess whether the current pace is appropriate
Pause the taper if symptoms become difficult — holding the current dose until symptoms stabilize is a common and appropriate strategy
Limit alcohol — it can worsen dizziness, mood changes, and sleep disruption during discontinuation
Prioritize sleep and exercise — both support nervous system regulation and mood stability during the adjustment period
Continue therapy if you are in it — having emotional support and cognitive tools in place before and during the taper significantly improves outcomes
Distinguishing Discontinuation from Relapse
One of the most important and sometimes difficult questions during a Lexapro taper is whether worsening mood or anxiety reflects discontinuation syndrome or a return of the underlying condition. The distinction matters because the responses differ — discontinuation calls for slowing the taper, while relapse may call for resuming full treatment.
Some distinguishing features:
Discontinuation symptoms typically begin within 2 to 4 days of a dose reduction and often include physical symptoms like dizziness, nausea, and brain zaps — symptoms not typical of depression or anxiety alone
Relapse symptoms tend to emerge more gradually (usually measured between 6-12 months post treatment) and often resemble the original condition/episode that prompted treatment (persistent low mood, hopelessness, pervasive worry)
Discontinuation symptoms often improve within days to weeks without dose changes, though in some cases, symptoms may persist longer; relapse symptoms persist and typically worsen over time
When the picture is unclear — which it often is — contact your prescriber rather than trying to make the call yourself. Temporarily returning to a higher dose and re-tapering more slowly is a safe and effective strategy when the line is hard to draw.
When to Stop the Taper and Seek Help
Contact your prescriber promptly if you experience any of the following during your taper:
Significant worsening of depression or anxiety, especially if accompanied by hopelessness or withdrawal from daily life
Any thoughts of self-harm or suicide — call or text 988 immediately
Symptoms severe enough to interfere with work, relationships, or basic functioning
Symptoms that are not improving over time or becoming difficult to manage
Any physical symptoms that concern you or don't fit the expected discontinuation pattern
After Stopping Lexapro: What Comes Next
Once you have fully tapered off Lexapro, ongoing monitoring remains important — particularly in the first 3 to 6 months. Research shows this period carries a higher risk of relapse, especially for people who have had multiple depressive episodes.
Having a plan in place before you stop can make a meaningful difference. That plan might include continued therapy, regular check-ins with your prescriber, and a clear understanding of early warning signs that would signal the need to resume treatment. Stopping antidepressants is not a failure; returning to them when needed is not a failure either. For many people, antidepressants are a long-term part of mental health management, and that is a completely valid outcome.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Never stop or reduce your medication without consulting your prescriber. For mental health crises, call or text 988.
Sources
Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538–546. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30032-X/abstract
American Psychiatric Association. (n.d.). What is depression? https://www.psychiatry.org/patients-families/depression/what-is-depression
Landy K, Rosani A, Estevez R. Escitalopram. [Updated 2023 Nov 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557734/
U.S. Food and Drug Administration. (2024). Lexapro (escitalopram) tablets and oral solution: Prescribing information (Reference ID: 5367836). https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021323s058lbl.pdf
Hu, Y., Xue, H., Ni, X., Guo, Z., et al. (2024). Association between duration of antidepressant treatment for major depressive disorder and relapse rate after discontinuation: A meta-analysis. Psychiatry Research, 337, 115926. https://www.sciencedirect.com/science/article/abs/pii/S0165178124002117
National Institute of Mental Health. (2024). Depression (NIH Publication No. 24-MH-8079). U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/depression
Cleveland Clinic. (2023, August 30). Antidepressant discontinuation syndrome. https://my.clevelandclinic.org/health/diseases/25218-antidepressant-discontinuation-syndrome
Henssler, J., Schmidt, Y., Schmidt, U., et al. (2024). Incidence of antidepressant discontinuation symptoms: A systematic review and meta-analysis. The Lancet Psychiatry, 11(7), 526–535. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00133-0/fulltext .
Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111–121. https://www.sciencedirect.com/science/article/pii/S0306460318308347
Gabriel, M., & Sharma, V. (2017). Antidepressant discontinuation syndrome. CMAJ : Canadian Medical Association journal, 189(21), E747. https://pmc.ncbi.nlm.nih.gov/articles/PMC5449237/
Gallo, A.T., Hulse, G.K. (2022). Hyperbolic dose reduction of escitalopram mitigates withdrawal syndrome: A case report. Psychiatry Research Case Reports, 1(1), 100009. https://www.sciencedirect.com/science/article/pii/S2773021222000098
Harvard Health Publishing. (2022, May 15). Going off antidepressants. https://www.health.harvard.edu/diseases-and-conditions/going-off-antidepressants
